INMB
Price
$10.63
Change
+$2.25 (+26.88%)
Updated
Apr 22, 6:59 PM EST
8 days until earnings call
MDGL
Price
$213.49
Change
+$1.45 (+0.68%)
Updated
Apr 22, 6:59 PM EST
14 days until earnings call
Ad is loading...

Analysis and predictions INMB vs MDGL

Header iconINMB vs MDGL Comparison
Open Charts INMB vs MDGLBanner chart's image
INmune Bio
Price$10.63
Change+$2.25 (+26.88%)
Volume$440.33K
CapitalizationN/A
Madrigal Pharmaceuticals
Price$213.49
Change+$1.45 (+0.68%)
Volume$304.04K
CapitalizationN/A
View a ticker or compare two or three
INMB vs MDGL Comparison Chart

Loading...

INMBDaily Signal changed days agoGain/Loss if shorted
 
Show more...
MDGLDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
INMB vs. MDGL commentary
Apr 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is INMB is a Hold and MDGL is a StrongSell.

COMPARISON
Comparison
Apr 23, 2024
Stock price -- (INMB: $10.63 vs. MDGL: $213.49)
Brand notoriety: INMB and MDGL are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: INMB: 669% vs. MDGL: 131%
Market capitalization -- INMB: $194.78M vs. MDGL: $4.48B
INMB [@Biotechnology] is valued at $194.78M. MDGL’s [@Biotechnology] market capitalization is $4.48B. The market cap for tickers in the [@Biotechnology] industry ranges from $557.83B to $0. The average market capitalization across the [@Biotechnology] industry is $2.53B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

INMB’s FA Score shows that 0 FA rating(s) are green whileMDGL’s FA Score has 0 green FA rating(s).

  • INMB’s FA Score: 0 green, 5 red.
  • MDGL’s FA Score: 0 green, 5 red.
According to our system of comparison, MDGL is a better buy in the long-term than INMB.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

INMB’s TA Score shows that 5 TA indicator(s) are bullish while MDGL’s TA Score has 4 bullish TA indicator(s).

  • INMB’s TA Score: 5 bullish, 4 bearish.
  • MDGL’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, INMB is a better buy in the short-term than MDGL.

Price Growth

INMB (@Biotechnology) experienced а +10.91% price change this week, while MDGL (@Biotechnology) price change was -7.73% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.60%. For the same industry, the average monthly price growth was -5.24%, and the average quarterly price growth was +1242.63%.

Reported Earning Dates

INMB is expected to report earnings on Aug 06, 2024.

MDGL is expected to report earnings on Aug 06, 2024.

Industries' Descriptions

@Biotechnology (-3.60% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for INMB with price predictions.
OPEN
A.I.dvisor published
a Summary for MDGL with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
MDGL($4.48B) has a higher market cap than INMB($195M). INMB YTD gains are higher at: -5.639 vs. MDGL (-7.732).
INMBMDGLINMB / MDGL
Capitalization195M4.48B4%
EBITDAN/AN/A-
Gain YTD-5.639-7.73273%
P/E RatioN/AN/A-
RevenueN/AN/A-
Total CashN/AN/A-
Total DebtN/AN/A-
FUNDAMENTALS RATINGS
MDGL: Fundamental Ratings
MDGL
OUTLOOK RATING
1..100
63
VALUATION
overvalued / fair valued / undervalued
1..100
68
Overvalued
PROFIT vs RISK RATING
1..100
54
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
58
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
INMBMDGL
RSI
ODDS (%)
Bullish Trend 1 day ago
89%
Bullish Trend 1 day ago
78%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
70%
Bullish Trend 1 day ago
85%
Momentum
ODDS (%)
Bullish Trend 1 day ago
76%
Bearish Trend 1 day ago
86%
MACD
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
78%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
81%
Bearish Trend 1 day ago
81%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
78%
Advances
ODDS (%)
Bullish Trend 14 days ago
84%
Bullish Trend 27 days ago
78%
Declines
ODDS (%)
Bearish Trend 7 days ago
88%
Bearish Trend 5 days ago
80%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 1 day ago
74%
Aroon
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
71%
View a ticker or compare two or three
Ad is loading...
INMBDaily Signal changed days agoGain/Loss if shorted
 
Show more...
MDGLDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
SPRE18.460.17
+0.93%
SP Funds S&P Global REIT Sharia ETF
SECT47.800.39
+0.82%
Main Sector Rotation ETF
DJUL37.940.27
+0.71%
FT Cboe Vest US Equity Deep Bffr ETF Jul
ROSC39.350.18
+0.47%
Hartford Multifactor Small Cap ETF
RATE21.70-0.09
-0.41%
Global X Interest Rate Hedge ETF

INMB and

Correlation & Price change

A.I.dvisor indicates that over the last year, INMB has been loosely correlated with MDGL. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if INMB jumps, then MDGL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INMB
1D Price
Change %
INMB100%
+26.94%
MDGL - INMB
41%
Loosely correlated
+0.68%
ORMP - INMB
38%
Loosely correlated
+2.64%
AXON - INMB
37%
Loosely correlated
+0.07%
CYTK - INMB
34%
Loosely correlated
-1.87%
AUTL - INMB
33%
Loosely correlated
+0.88%
More

MDGL and

Correlation & Price change

A.I.dvisor indicates that over the last year, MDGL has been loosely correlated with IBRX. These tickers have moved in lockstep 62% of the time. This A.I.-generated data suggests there is some statistical probability that if MDGL jumps, then IBRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MDGL
1D Price
Change %
MDGL100%
+0.68%
IBRX - MDGL
62%
Loosely correlated
-6.26%
KA - MDGL
62%
Loosely correlated
+20.47%
VXRT - MDGL
61%
Loosely correlated
+0.91%
RLAY - MDGL
57%
Loosely correlated
-0.17%
VBIV - MDGL
57%
Loosely correlated
-4.84%
More